KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Procter & Gamble (PG) Capital Expenditures (2016 - 2025)

Procter & Gamble (PG) has disclosed Capital Expenditures for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Capital Expenditures rose 26.16% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 billion, a 20.7% increase, with the full-year FY2025 number at $3.8 billion, up 13.58% from a year prior.
  • Capital Expenditures was $1.2 billion for Q4 2025 at Procter & Gamble, down from $1.2 billion in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $1.2 billion in Q3 2025 to a low of $626.0 million in Q4 2021.
  • A 5-year average of $852.5 million and a median of $807.0 million in 2023 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: rose 28.35% in 2021, then decreased 18.42% in 2022.
  • Procter & Gamble's Capital Expenditures stood at $626.0 million in 2021, then rose by 13.1% to $708.0 million in 2022, then grew by 15.4% to $817.0 million in 2023, then rose by 13.22% to $925.0 million in 2024, then increased by 26.16% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for PG's Capital Expenditures are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $996.0 million (Q2 2025).